Hainan Changan International Pharmaceutical Co. Ltd.

Hainan Changan International Pharmaceutical Co., Ltd. (originally named Hainan Tianwang International Pharmaceutical Co., Ltd.), founded in August 19th, 1993, is specialized in the production and sale of pharmaceutical raw materials and preparations and, renamed Hainan Changan International Pharmaceutical Co., Ltd. in January 15th, 2003. Hainan Changan International Pharmaceutical Co., Ltd. is a national high-tech research and development plan (863 plan) project enterprise, national torch plan key high-tech enterprises, national Development and Reform Commission high-tech industrialization demonstration project enterprise, national innovative enterprises pilot units, national biochemical engineering technology research center of biological pharmaceutical industry base.  Hainan Changan International Pharmaceutical Co., Ltd. is engaged in research and development, production and marketing of pharmaceutical raw materials and preparations with a registered capital of RMB 81.63 million. The present personnel is 125( of personnel with master degree or above: 2%, personnel with college degree or above: 35%, middle and senior technicians: 26 persons) and personnel in the corresponding type of work and the post office all have qualification certificate. The existing APIs(Lobaplatin), powder for injection, large capacity injection and lyophilized powder for injection of four production lines, all have passed national GMP certification. Since its establishment, the company enjoys a rapid development with continuously comprehensive strengths, enjoying good social reputation and winning many domestic and international honors. As a key high-tech enterprise of national torch plan, the company successively undertakes several technology projects, including three projects of the national torch plan projects, one project of the national high-tech industrialization demonstration projects of Development and Reform Commission, two projects of National New Products Program, one project of national “813” plan, two projects of key science and technology plan projects of Hainan province, 2 projects of key science and technology plan projects of Haikou City, etc. The national, provincial and municipal scientific research projects progress smoothly and have entered the industrialization of production, occupied more than 90% of the proportion in the total industrialoutput  value. The company has been awarded a key national high-tech enterprise and the top 50 industrial enterprises in Hainan province for consecutive years. The company is located in the beautiful scenery of the Hainan Province, Haikou National Hi-tech Industrial Development Zone. Currently we mainly produce the following products: Lobaplatin and Lobaplatin for Injection (National Class I new drug, exclusive products), Fructose Sodium Diphosphate for Injection, etc. Fructose Sodium Diphosphate for Injection (" FoDi”: famous trademark in Hainan province ") enjoys the national market share to a certain extent. Sales of the exclusive Lobaplatin for Injection (National Class I new drug, global patent products) rise year by year since it is put into market, and this product has become the main product for company's main profit-growth point. In the process of company’s twenty-year development, the company has always been vigorously supported and cared by governments and leaders at all levels. Over the years, in the preferential policy environment of increasing support for high-tech industry development in Hainan province, it responses the national call and constantly sticks to product technological innovation as its guide, with the development strategy considering patent as its barrier, so as to maintain faster development speed and higher profit of the company in the fierce competition. The company believes in "Healthy life, Changan companies", and its mansion is to  reduce human disease pain and improve people's quality of life. Service the state and repay the society.